Lindquist et al. show that GLP-1 and semaglutide, but not exendin 4 or GIP, selectively drive GLP-1R-GIPR heterodimerization, altering receptor trafficking and signaling. These findings uncover a...
Sep 17, 2026 · 9:01 PM UTC